SPINOTONE

This brand name is authorized in Nigeria.

Active ingredients

The drug SPINOTONE contains one active pharmaceutical ingredient (API):

1	Spironolactone UNII 27O7W4T232 - SPIRONOLACTONE
	Spironolactone, as a competitive aldosterone antagonist, increases sodium excretion whilst reducing potassium loss at the distal renal tubule. It has a gradual and prolonged action.
	Read more about Spironolactone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-7782	Tablet	Spinotone-25 Tablets TAB 25 mg		16/12/2021
B4-5201	Tablet	Spinotone-50 Tablets TAB 50 mg		02/12/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C03DA01	Spironolactone	C Cardiovascular system → C03 Diuretics → C03D Potassium-sparing agents → C03DA Aldosterone antagonists
Discover more medicines within C03DA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-7782, B4-5201